KORU Medical Systems, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by KORU Medical Systems, Inc. (KRMD) on August 13, 2026. The report addresses a corporate governance amendment adopted by the Board of Directors effective on the date of the report.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or performance metrics.
Material Changes
The Board of Directors unanimously adopted a resolution to amend Section 3.05 of the Company's Amended and Restated By-laws. The amendment clarifies that the authority to remove a director is vested exclusively in the affirmative vote of shareholders holding a majority of the Company's outstanding shares, in compliance with the Delaware General Corporation Law. The Board stated it has not previously voted to remove, nor has it had any intention or agreement to remove, any director.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document is strictly limited to the procedural amendment of the By-laws.
Key Facts for Investor Verification
- The amendment to the By-laws regarding director removal was effective as of August 13, 2026.
- Director removal now requires an affirmative vote of shareholders holding a majority of outstanding shares.
- The Board explicitly stated there is no current intention or agreement to remove any director.
- Exhibit 3.1 contains the full text of Amendment No. 1 to the Amended and Restated By-laws.